Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
PMV Pharmaceuticals, Inc
Mayo Clinic
Tizona Therapeutics, Inc
Essen Biotech
Novartis
Memorial Sloan Kettering Cancer Center
Incyte Corporation
Trishula Therapeutics, Inc.
Thomas Jefferson University
Inhibrx Biosciences, Inc
Celldex Therapeutics
University of California, San Francisco
Corvus Pharmaceuticals, Inc.
Cantargia AB
Kineta Inc.
Viralytics
Cambridge University Hospitals NHS Foundation Trust
Incyte Corporation
Incyte Corporation
Syndax Pharmaceuticals
Gary Onik MD